237 related articles for article (PubMed ID: 15556770)
61. Ultrasound-assisted Synthesis of 6-substituted indolo[2,3-b]quinolines: their Evaluation as Potential Cytotoxic Agents.
Marepu N; Gosi M; Vedula SS; Yeturu S; Pal M
Mini Rev Med Chem; 2019; 19(7):599-608. PubMed ID: 30058486
[TBL] [Abstract][Full Text] [Related]
62. Synthesis and biological evaluation of new penta- and heptacyclic indolo- and quinolinocarbazole ring systems obtained via Pd(0) catalysed reductive N-heteroannulation.
Laronze-Cochard M; Cochard F; Daras E; Lansiaux A; Brassart B; Vanquelef E; Prost E; Nuzillard JM; Baldeyrou B; Goosens JF; Lozach O; Meijer L; Riou JF; Henon E; Sapi J
Org Biomol Chem; 2010 Oct; 8(20):4625-36. PubMed ID: 20734015
[TBL] [Abstract][Full Text] [Related]
63. Design, synthesis and qualitative structure-activity evaluations of novel hexahydropyrano[3,2-c][1,2]diazepin-3(4H)-one and tetrahydropyrano[3,2-b]pyrrol-2(1H)-one derivatives as anticancer agents.
Al-Tel TH
Eur J Med Chem; 2010 Oct; 45(10):4615-21. PubMed ID: 20691507
[TBL] [Abstract][Full Text] [Related]
64. Heterocyclic quinones. XIV. Pharmacomodulation in a series of 11H-indolo[3,2-c]quinolinediones: synthesis and cytotoxicity of 8-substituted 11H-indolo[3,2-c]quinoline-7,10-diones.
Helissey P; Giorgi-Renault S; Renault J; Cros S
Chem Pharm Bull (Tokyo); 1989 Mar; 37(3):675-9. PubMed ID: 2752476
[TBL] [Abstract][Full Text] [Related]
65. Synthesis and cytotoxic activity evaluation of indolo-, pyrrolo-, and benzofuro-quinolin-2(1H)-ones and 6-anilinoindoloquinoline derivatives.
Chen YL; Chung CH; Chen IL; Chen PH; Jeng HY
Bioorg Med Chem; 2002 Aug; 10(8):2705-12. PubMed ID: 12057659
[TBL] [Abstract][Full Text] [Related]
66. Synthesis of 5,6-dimethyl-9-methoxy-1-phenyl-6H-pyrido[4,3-b]carbazole derivatives and their cytotoxic activity.
Jasztold-Howorko R; Pelczynska M; Nasulewicz A; Wietrzyk J; Opolski A
Arch Pharm (Weinheim); 2005 Nov; 338(11):556-61. PubMed ID: 16281305
[TBL] [Abstract][Full Text] [Related]
67. Synthesis and antitumor activity of fused quinoline derivatives. III. Novel N-glycosylamino-indolo[3,2-b]quinolines.
Takeuchi Y; Chang MR; Hashigaki K; Tashiro T; Tsuruo T; Tsukagoshi S; Yamato M
Chem Pharm Bull (Tokyo); 1992 Jun; 40(6):1481-5. PubMed ID: 1394666
[TBL] [Abstract][Full Text] [Related]
68. Novel 4H-1,3,4-oxadiazin-5(6H)-ones with hydrophobic and long alkyl chains: design, synthesis, and bioactive diversity on inhibition of monoamine oxidase, chitin biosynthesis and tumor cell.
Ke SY; Qian XH; Liu FY; Wang N; Yang Q; Li Z
Eur J Med Chem; 2009 May; 44(5):2113-21. PubMed ID: 19027994
[TBL] [Abstract][Full Text] [Related]
69. Synthesis and antitumor activity of novel amsacrine analogs: the critical role of the acridine moiety in determining their biological activity.
Chilin A; Marzaro G; Marzano C; Dalla Via L; Ferlin MG; Pastorini G; Guiotto A
Bioorg Med Chem; 2009 Jan; 17(2):523-9. PubMed ID: 19101158
[TBL] [Abstract][Full Text] [Related]
70. An expeditious I2-catalyzed entry into 6H-indolo[2,3-b]quinoline system of cryptotackieine.
Parvatkar PT; Parameswaran PS; Tilve SG
J Org Chem; 2009 Nov; 74(21):8369-72. PubMed ID: 19788169
[TBL] [Abstract][Full Text] [Related]
71. The usefulness of cyclic diamidines with different core-substituents as antitumor agents.
Spychała J
Bioorg Chem; 2008 Aug; 36(4):183-9. PubMed ID: 18571215
[TBL] [Abstract][Full Text] [Related]
72. Synthesis and antiproliferative activity in vitro of novel (2-butynyl)thioquinolines.
Mól W; Matyja M; Filip B; Wietrzyk J; Boryczka S
Bioorg Med Chem; 2008 Sep; 16(17):8136-41. PubMed ID: 18682326
[TBL] [Abstract][Full Text] [Related]
73. Synthesis of novel thiazolone-based compounds containing pyrazoline moiety and evaluation of their anticancer activity.
Havrylyuk D; Zimenkovsky B; Vasylenko O; Zaprutko L; Gzella A; Lesyk R
Eur J Med Chem; 2009 Apr; 44(4):1396-404. PubMed ID: 19000643
[TBL] [Abstract][Full Text] [Related]
74. Synthesis, cytotoxic evaluation, and DNA binding of novel thiazolo[5,4-b]quinoline derivatives.
Loza-Mejía MA; Maldonado-Hernández K; Rodríguez-Hernández F; Rodríguez-Sotres R; González-Sánchez I; Quintero A; Solano JD; Lira-Rocha A
Bioorg Med Chem; 2008 Feb; 16(3):1142-9. PubMed ID: 18035542
[TBL] [Abstract][Full Text] [Related]
75. Synthesis and anticancer activity of new class of bisphosphonates/phosphanamidates.
Kiran YB; Devendranath Reddy C; Gunasekar D; Suresh Reddy C; Leon A; Barbosa LC
Eur J Med Chem; 2008 Apr; 43(4):885-92. PubMed ID: 17640773
[TBL] [Abstract][Full Text] [Related]
76. 8-Methyl-4-(3-diethylaminopropylamino) pyrimido [4',5';4,5] thieno (2,3-b) quinoline (MDPTQ), a quinoline derivate that causes ROS-mediated apoptosis in leukemia cell lines.
Shenoy S; Vasania VS; Gopal M; Mehta A
Toxicol Appl Pharmacol; 2007 Jul; 222(1):80-8. PubMed ID: 17553538
[TBL] [Abstract][Full Text] [Related]
77. Synthesis, antitumor and anti-HIV activities of benzodithiazine-dioxides.
Brzozowski Z; Saczewski F; Neamati N
Bioorg Med Chem; 2006 May; 14(9):2985-93. PubMed ID: 16406643
[TBL] [Abstract][Full Text] [Related]
78. Quinoline-imidazole/benzimidazole derivatives as dual-/multi-targeting hybrids inhibitors with anticancer and antimicrobial activity.
Diaconu D; Antoci V; Mangalagiu V; Amariucai-Mantu D; Mangalagiu II
Sci Rep; 2022 Oct; 12(1):16988. PubMed ID: 36216981
[TBL] [Abstract][Full Text] [Related]
79. Synthesis and anticancer activity of (R,S)-9-(2,3-dihydro-1,4-benzoxathiin-3-ylmethyl)-9H-purines.
Díaz-Gavilán M; Conejo-García A; Cruz-López O; Núñez MC; Choquesillo-Lazarte D; González-Pérez JM; Rodríguez-Serrano F; Marchal JA; Aránega A; Gallo MA; Espinosa A; Campos JM
ChemMedChem; 2008 Jan; 3(1):127-35. PubMed ID: 18022976
[TBL] [Abstract][Full Text] [Related]
80. Synthesis and in vitro antiproliferative activities of quinoline derivatives.
Broch S; Aboab B; Anizon F; Moreau P
Eur J Med Chem; 2010 Apr; 45(4):1657-62. PubMed ID: 20106562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
